Trimethoprim-sulfamethoxazole hepatotoxicity is liver damage caused by the antibiotic combination trimethoprim-sulfamethoxazole. This medication is also known as TMP-SMX, co-trimoxazole, or by the brand name Bactrim. It treats bacterial infections including urinary tract infections, respiratory infections, and certain skin infections.
The antibiotic can trigger an immune reaction or direct chemical injury to liver cells. This causes cholestatic liver injury, which means bile cannot flow properly from the liver. It can also cause mixed liver injury, where both bile flow and liver cell function are affected. Most cases develop within the first few weeks of starting the medication.
The condition ranges from mild enzyme elevations to severe liver injury. Most people recover fully after stopping the medication. Early detection through blood testing helps prevent serious complications. Understanding your risk factors and monitoring your liver function can protect your health during antibiotic treatment.